GlaxoSmithKline PLC (NYSE:GSK)
| 39.59 Delayed Data As of May 17 |  +0.51 / +1.29%Today’s Change | 33.26 Today|||52-Week Range 42.77 | +7.57% Year-to-Date |
GSK Regular Dividend: GSK will begin trading ex-dividend on 05/20/21 with a $0.527 dividend payable to shareholders of record as of 05/21/21.
Latest GSK News | Press Releases
Today’s Trading
| Previous close | 39.08 |
| Today’s open | 39.02 |
| Day’s range | 38.99 - 39.70 |
| Volume | 4,702,576 |
| Average volume (3 months) | 5,690,897 |
| Market cap | $94.7B |
Data as of 3:59pm ET, 05/17/2021
Growth & Valuation
| Earnings growth (last year) | +23.68% |
| Earnings growth (this year) | -13.74% |
| Earnings growth (next 5 years) | +4.26% |
| Revenue growth (last year) | +1.55% |
| P/E ratio | 13.4 |
| Price/Sales | 2.12 |
| Price/Book | 4.70 |
Competitors
Data as of 4:00pm ET, 05/17/2021
Financials
| Next reporting date | July 28, 2021 |
| EPS forecast (this quarter) | $0.56 |
| Annual revenue (last year) | $43.7B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
